Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance
Fractyl Health announced a virtual Commercial Strategy Day for September 1, 2026, to discuss the commercialization potential and go-to-market plan for Revita®, their procedural therapy designed to maintain weight loss after GLP-1 treatment cessation. This follows encouraging one-year data showing significant weight maintenance after a single Revita…